An efficient method for the synthesis of peptide aldehyde libraries employed in the discovery of reversible SARS coronavirus main protease (SARS-CoV Mpro) inhibitors

被引:51
作者
Al-Gharabli, Samer I.
Shah, Syed T. Ali
Weik, Steffen
Schmidt, Marco F.
Mesters, Jeroen R.
Kuhn, Daniel
Klebe, Gerhard
Hilgenfeld, Rolf
Rademann, Joerg
机构
[1] Univ Lubeck, Inst Biochem, Ctr Struct & Cell Biol Med, D-23538 Lubeck, Germany
[2] Univ Marburg, Inst Pharmazeut Chem, D-35032 Marburg, Germany
[3] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany
[4] Leibniz Inst Mol Pharmacol, Dept Med Chem, D-13125 Berlin, Germany
关键词
aldehydes; cysteine proteases; inhibitors; SARS; solid-phase synthesis; viruses;
D O I
10.1002/cbic.200500533
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A method for the parallel solid-phase synthesis of peptide aldehydes has been developed. Protected amino acid aldehydes obtained by the racemization-free oxidation of amino alcohols with Dess-Martin periodinane were immobilized on threonyl resins as oxazolidines. Following Boc protection of the ring nitrogen to yield the N-protected oxazolidine linker, peptide synthesis was performed efficiently on this resin. A peptide aldehyde library was designed for targeting the SARS coronavirus main protease, SARS-CoV M-pro (also known as 3CL(pro)), on the basis of three different reported binding modes and supported by virtual screening. A set of 25 peptide aldehydes was prepared by this method and investigated in inhibitions assays against SARS-CoV M-pro. Several potent inhibitors were found with IC50 values in the low micromolar range. An IC50 of 7.5 mu M was found for AcNSTSQ-H and AcESTLQ-H. Interestingly, the most potent inhibitors seem to bind to SARS-CoV M-pro in a noncanonical binding mode.
引用
收藏
页码:1048 / 1055
页数:8
相关论文
共 41 条
  • [1] ASYMMETRIC-SYNTHESIS OF HOMOCHIRAL 1,2-DIOLS VIA N-BOC OXAZOLIDINES
    AGAMI, C
    COUTY, F
    LEQUESNE, C
    [J]. TETRAHEDRON LETTERS, 1994, 35 (20) : 3309 - 3312
  • [2] Coronavirus main proteinase (3CLpro) structure:: Basis for design of anti-SARS drugs
    Anand, K
    Ziebuhr, J
    Wadhwani, P
    Mesters, JR
    Hilgenfeld, R
    [J]. SCIENCE, 2003, 300 (5626) : 1763 - 1767
  • [3] Anand K, 2005, BIRK ADV INFECT DIS, P173
  • [4] SCREENING FOR FIBRINOLYSIS INHIBITORY EFFECT OF SYNTHETIC THROMBIN INHIBITORS
    BARABAS, E
    SZELL, E
    BAJUSZ, S
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1993, 4 (02) : 243 - 248
  • [5] Baumeister EG, 2005, MEDICINA-BUENOS AIRE, V65, P36
  • [6] Solid-phase synthesis of oligourea peptidomimetics employing the Fmoc protection strategy
    Boeijen, A
    van Ameijde, J
    Liskamp, RMJ
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 2001, 66 (25) : 8454 - 8462
  • [7] Coronavirus genome structure and replication
    Brian, DA
    Baric, RS
    [J]. CORONAVIRUS REPLICATION AND REVERSE GENETICS, 2005, 287 : 1 - 30
  • [8] PREPARATIONS OF PSI-PEPTIDE BOND AND PEPTIDE-ALDEHYDE INHIBITORS OF ATRIAL GRANULE SERINE PROTEINASE, A CANDIDATE PROCESSING ENZYME OF PROATRIAL NATRIURETIC FACTOR
    DAMODARAN, A
    HARRIS, RB
    [J]. JOURNAL OF PROTEIN CHEMISTRY, 1995, 14 (06): : 431 - 440
  • [9] Conservation medicine and a new agenda for emerging diseases
    Daszak, P
    Tabor, GM
    Kilpatrick, AM
    Epstein, J
    Plowright, R
    [J]. IMPACT OF ECOLOGICAL CHANGES ON TROPICAL ANIMAL HEALTH AND DISEASE CONTROL, 2004, 1026 : 1 - 11
  • [10] A simple linker for the attachment of aldehydes to the solid phase. Application to solid phase synthesis by the Multipin(TM) method.
    Ede, NJ
    Bray, AM
    [J]. TETRAHEDRON LETTERS, 1997, 38 (40) : 7119 - 7122